CD19 and rheumatoid arthritis: Furthermore, RA patients were characterized by an expansion of immature B cells (CD19+CD24+CD38+) and plasma cells (CD19+CD27+CD38+) compared to controls, and low cognitive scores were correlated with bigger proportions of immature B cells [85].